137P First-in-human results from a phase I dose-escalation study of VSV-GP (BI 1831169) in patients with advanced solid tumors

Autor: Champiat, S., Italiano, A., Wagle, N., Lauer, U.M., Quinson, A-M., Luecke, S., Hern, V., Porosnicu, M.
Zdroj: In Immuno-Oncology and Technology December 2023 20 Supplement
Databáze: ScienceDirect